НовостиBenzingaCity Therapeutic Doses First Patient In Its Clinical Study Of CITY-RBP4 To Treat Stargardt Disease Type 1 City Therapeutic Doses First Patient In Its Clinical Study Of CITY-RBP4 To Treat Stargardt Disease Type 1 Benzinga 2026.11.10 12:04 (GMT+0) Открыть на Benzinga Другие новости